Femasys Inc. (FEMY) Reports In-Line Q2 EPS

Femasys Inc. (NASDAQ: FEMY) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Femasys Inc. (FEMY) click here.

You May Also Be Interested In

• Kura Oncology (KURA) Tops Q2 EPS by 11c, Beats on Revenue
• Madison Square Garden Entertainment (MSGE) PT Raised to $103 at Guggenheim
• Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG